Kamil Faridi MD MSc (@kfaridiMD) header
Kamil Faridi MD MSc (@kfaridiMD) profile picture

Cardiologist | Outcomes Researcher @YaleCardiology Alum: @DukeMedSchool @HopkinsMedicine @BidmcCvi

New Haven, CT
Joined March 2018
Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)Photo by Kamil Faridi MD MSc (@kfaridiMD)
Our New Study in @JACCJournals : Are LDL-C/non-HDL-C/apoB associated with coronary atherosclerosis in low-risk, otherwise healthy U.S. adults without HTN, diabetes, or tobacco use? jacc.org/doi/10.1016/j.jacad…
7
38
7
114
35,273
Can Lp(a) testing change statin decisions for adults considered low risk for ASCVD? Our analysis in AHJ Plus attempts to answer this: sciencedirect.com/science/ar…
1
2
703
In summary - integrating Lp(a) into ASCVD risk equations changes predicted risk and could impact potential statin eligibility in a small number of low-risk adults with high Lp(a) not already indicated for statins. More data needed on how Lp(a) may impact 30-yr risk estimates.
1
39
Kamil Faridi MD MSc retweeted
New in @AJPCardio: Under the 2026 ACC/AHA dyslipidemia guideline, over 60% of U.S. adults aged 30-79 without ASCVD now have a statin indication, up from 43% under the 2018 guideline. That’s 31.3 million newly eligible Americans. But only 1 in 4 eligible adults are currently on therapy. 🔗 sciencedirect.com/science/ar…
7
25
68
30,726
🥸 Congratulations to the Yale group and to @JACCJournals 😱 Full citation is here: jacc.org/doi/epdf/10.1016/j.…
1
1
7
666
Kamil Faridi MD MSc retweeted
3 in 10 US adults aged 30 to 79 yrs have #CVD or high 10-yr risk, including over 90% of those 65+. 2/3 of middle-aged adults face elevated 30-yr risk, especially men & Black & Hispanic individuals—highlighting urgent need for stronger #cvPrev efforts jacc.org/doi/10.1016/j.jacc.… #JACC
5
18
3,544
Kamil Faridi MD MSc retweeted
NEW IN @JACCJournals What are the 10-year and 30-year risks of cardiovascular disease in the U.S.? We evaluated this using the AHA @American_Heart PREVENT equations. jacc.org/doi/10.1016/j.jacc.…
1
2
4
220
Kamil Faridi MD MSc retweeted
Let’s talk about a case that made doctors rethink cannabis and the heart. A 21-year-old in Italy, healthy and active, smoked marijuana one night in 2016—and ended up in the ER with a heart attack. Sounds shocking, right? But there’s more to it. Let’s break it down:
7
26
2
55
21,201
Kamil Faridi MD MSc retweeted
🚨 New in JACC: Advances! We analyzed NHANES data pre/post-COVID to examine trends in lipid-lowering therapy (LLT) among U.S. adults. ✅ LLT use increased modestly post-pandemic, especially among women and Black adults. 🚫 But <40% of eligible adults still receive LLT. sciencedirect.com/science/ar… #CardioTwitter #epitwitter #LLT #ASCVD #PreventionStartsWithMe @kfaridiMD @yuan_lu1
1
4
329